##
##
##
|Names and addresses
ofadvisers|(Optional
information)|(Optional
information)||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|T
e ofadviser
Name||Address||||||||||||
|Name ofchief executive or names|ofsenior staff members||(Optional|||information)||||||||
|Description
ofthe charity's trusts||||||||||||||
|Type of governing
document|Constitution|||||||||||||
|How the charity is constituted|Charitable|Incorporated|Organisation|||||||||||
|Trustee selection methods|Appointed|by existing trustees||||||||||||
|Additional
governance
issues|(Optional
information)|||||||||||||
|You may choose to include
additional
information,
where
relevant,
about:|Charlotte's
BAG works closely with
King College Hospital,
London
in
Charlotte's
Lab. Research
into glioblastoma
is undertaken
under the
guidance
ofseven ofthe world's
top neuro-oncologists,
neurosurgeons
and pathologists.|||||||||||||
|~
policies and procedures||||||||||||||
|adopted
for the induction
and||||||||||||||
|training
oftrustees;||||||||||||||
|~
the charity's
organisational||||||||||||||
|structure
and any wider||||||||||||||
|network
with which the charity||||||||||||||
|works;||||||||||||||
|~
relationship
with any related||||||||||||||
|parties;||||||||||||||
|~
trustees'
consideration
of||||||||||||||
|major risks and the system||||||||||||||
|and procedures
to manage||||||||||||||
|them.||||||||||||||
||To provide|funds to perform||research|||into Glioblastoma,|||its|causes,|||
||treatment
and cure to ensure that the||||||useful|results of||such|research are|||
|Summary
ofthe objects ofthe
charity set out in its governing
document|published.
To advance the education
involved
in the diagnosis,
treatments
Glioblastoma.||||||ofthe public,
in particulate
and care ofthose suffering|||||those
from||
|Summary
ofthe main activities||||||||||||||
|undertaken
for the public|Information|about glioblastoma|||is provided|||on our|website|||||
|benefit
in relation to these|www. charlottesba
.com|||||||||||||
|objects (include within this||||||||||||||
|TAR|||||||||||March||2012|
##
##
##
|O
('HApl7$ QpMM(ggipN
FOR EN6LAND
AND WALES|O
('HApl7$ QpMM(ggipN
FOR EN6LAND
AND WALES|O
('HApl7$ QpMM(ggipN
FOR EN6LAND
AND WALES|O
('HApl7$ QpMM(ggipN
FOR EN6LAND
AND WALES|O
('HApl7$ QpMM(ggipN
FOR EN6LAND
AND WALES|O
('HApl7$ QpMM(ggipN
FOR EN6LAND
AND WALES|O
('HApl7$ QpMM(ggipN
FOR EN6LAND
AND WALES|O
('HApl7$ QpMM(ggipN
FOR EN6LAND
AND WALES|O
('HApl7$ QpMM(ggipN
FOR EN6LAND
AND WALES||Charity
Name
har otte s
ag
Receipts and payments|Charity
Name
har otte s
ag
Receipts and payments|Charity
Name
har otte s
ag
Receipts and payments|Charity
Name
har otte s
ag
Receipts and payments|Charity
Name
har otte s
ag
Receipts and payments|Charity
Name
har otte s
ag
Receipts and payments|No (if any)
1169419
accounts|No (if any)
1169419
accounts|||CC&6a||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||For|the period
from|||Period start date
01/04/2020|To||Period end date
31/03/2021|||||
||'|||||||||||||||||||||
||||-||-|||||||||||||||||
|~|||||||~|.|~|~.||||||||||||
|||||||||||Unrestricted
funds||||Restricted
funds|Endowment
funds||Total|funds||Last year||
|||||||||||to the nearest||||to the nearest E|to the nearest R||to the nearest E||to|the nearest|K|
|||||||||||||E||||||||||
|A1 Receipts||||||||||||||||||||||
|Direct donations|||||||||||||5,378|||||5,378||14,360||
|Donations
via paypal|||||||||||||8,998|||||8,998||2,523||
|Sub total||(Gross|||income for
AR)||||||||14,376|||||14,376||16,883||
|A2 Asset and||investment|||||sales,|||||||||||||||
|(see table).||||||||||||||||||||||
|||||||Sub||total||||||||||||||
||||Total||||receipts||||||14,376|||||14,376||16,883||
|A3 Payments||||||||||||||||||||||
|Kings College Hospital|||||||||||||25,000|||||25,000||35,000||
|Admin Fees via|Paypal||||||||||||217|||||217||||
|Other|||||||||||||||||||||86|
|||||||Sub||total|||||25,217|||||25,217||35,086||
|A4 Asset and||investment||||||||||||||||||||
|purchases,|(see table)|||||||||||||||||||||
|||||||Sub||total||||||||||||||
|||Total|||payments||||||||25,217|||||25,217||35,086||
|Net ofreceiptsl(payments)|||||||||||||10,841|||||10,841|-|18,203||
|A5 Transfers||between||||funds||||||||||||||||
|A6 Cash funds last||||year|||end||||||27,382|||||27,382||||
|Cash funds|||this|||year||end|||||16,541|||||16,541||18,203||
||~|a|~||~|~|~|~|~
~|~|~|~||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||Unrestricted|Restricted|||Endowment|
|||Categories||||Details|||funds
to nearest F|to|funds
nearest f||funds
to nearest f|
|B1 Cash||funds||||Bank account|||15,159|||||
|||||||Paypal account|||1,382|||||
||||||||Total|cash funds|16,541|||||
|||||||(agree balances|with receipts and payments|||||||
|||||||||account(s))|OK|OK|||OK|
||||||||||Unrestricted|Restricted|||Endowment|
||||||||||funds||funds||funds|
|||||||Details|||to nearest f|to|nearest f||to nearest f|
|B2Other||monetary assets||||||||||||
|||||||Details|||Fund to which
asset belon
s|Cost (optional)|||Current value
o tional|
|B3Investment|||assets|||||||||||
|||||||Details|||Fund to which
asset belon s|Cost (optional)|||Current value
o tional|
|B4Assets retained for||||the||||||||||
|charity's||own|use|||||||||||
||||||||||Fund to which|Amount||due|When due|
|||||||Details|||liabili
relates||o tional||o tional|
|B5Liabilities||||||||||||||
|Signed
behalf|by one or two trustees
of all the trustees|||on||Signature|||Print|Name|||Date of
a proval|
||||||||||uwo~=r|||||